Bio-Techne Corp.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $321.2M | $311.4M | $295.9M | $286.6M | $317.0M | $316.2M | $297.0M | $289.5M |
| Cost of Revenue | $109.8M | $103.1M | $104.6M | $98.4M | $118.2M | $101.6M | $103.1M | $106.4M |
| Gross Profit | $211.4M | $208.3M | $191.3M | $188.1M | $198.8M | $214.6M | $193.9M | $183.0M |
| Gross Margin | 65.8% | 66.9% | 64.6% | 65.6% | 62.7% | 67.9% | 65.3% | 63.2% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $113.2M | $109.3M | $113.7M | $116.2M | $196.6M | $151.3M | $121.5M | $119.2M |
| Operating Income | $74.3M | $75.5M | $54.5M | $47.7M | $-23.9M | $38.7M | $47.4M | $40.0M |
| Operating Margin | 23.1% | 24.2% | 18.4% | 16.6% | -7.5% | 12.2% | 16.0% | 13.8% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $70.7M | $71.2M | $50.8M | $48.0M | $-22.9M | $38.3M | $42.9M | $40.2M |
| Income Tax Expense | $16.1M | $20.2M | $12.8M | $9.8M | $-5.2M | $15.7M | $8.0M | $6.6M |
| Net Income | $54.6M | $51.0M | $38.0M | $38.2M | $-17.7M | $22.6M | $34.9M | $33.6M |
| Net Margin | 17.0% | 16.4% | 12.8% | 13.3% | -5.6% | 7.1% | 11.7% | 11.6% |
| EPS (Basic) | $0.35 | $0.33 | $0.24 | $0.25 | $-0.10 | $0.14 | $0.22 | $0.21 |
| EPS (Diluted) | $0.36 | $0.32 | $0.24 | $0.24 | $-0.11 | $0.14 | $0.22 | $0.21 |
| Shares Outstanding (Basic) | 156.0M | 156.3M | 155.8M | 155.5M | 157.5M | 157.4M | 158.4M | 158.5M |
| Shares Outstanding (Diluted) | 157.0M | 157.4M | 157.0M | 156.4M | 159.7M | 158.9M | 160.6M | 161.1M |
| Dividends Per Share | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 |